Clinical trial
A Phase 3 Study of JNS013 in Patients With Chronic Pain
NCT00736853 is registered in ClinicalTrials.gov with Janssen Pharmaceutical K.K. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Study of JNS013 in Patients With Chronic Pain
- Lead sponsor
- Janssen Pharmaceutical K.K.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- January 31, 2009
- Enrollment
- 321 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.